Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Recent patents report novel analgesic agents

Jan. 29, 2008

Genome-wide analysis approach potentially useful to identify predictors of response to MS therapy

Jan. 29, 2008

Promising preclinical results for FGL in stress-induced cognitive deficits

Jan. 28, 2008

Novartis reports positive primary endpoint from the FIRST-STEP study of Stalevo

Jan. 28, 2008

First and only antiinflammatory pain relief patch available in the U.S.

Jan. 28, 2008

Combination of quetiapine and a mood stabilizer more effective in preventing mood episodes

Jan. 28, 2008

EMEA issues positive opinion of Cephalon's Effentora in breakthrough cancer pain

Jan. 25, 2008

Neurokinin 1 receptors linked to control of aggressiveness

Jan. 25, 2008

Sarcosine monotherapy assessed in schizophrenia patients

Jan. 25, 2008

Antidepressant-mGlu2/3 receptor agonist combination may improve depression

Jan. 25, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...